You just read:

OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa

News provided by

OliX Pharmaceuticals, Inc.

May 09, 2019, 21:24 ET